Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 28, 2012; 18(48): 7357-7361
Published online Dec 28, 2012. doi: 10.3748/wjg.v18.i48.7357
Published online Dec 28, 2012. doi: 10.3748/wjg.v18.i48.7357
Table 1 Comparison of Helicobacter pylori infection between gastric cancer and control groups
| Gastric cancer group (%) | Gastric atrophy group (%) | Control group (%) | P value | |
| No. | 450 | 111 | 961 | |
| H. pylori infection | ||||
| Negative | 139 (30.9) | 27 (24.3) | 483 (50.3) | |
| Positive | 311 (69.1) | 84 (75.7) | 478 (49.7) | < 0.001 |
| Sex | ||||
| Male | 324 (72.0) | 66 (59.5) | 564 (58.7) | < 0.001 |
| Female | 126 (28.0) | 45 (40.5) | 397 (41.3) | |
| Age | ||||
| < 45 yr | 38 (8.4) | 20 (18.0) | 285 (29.7) | < 0.001 |
| 45-65 yr | 240 (53.3) | 81 (73.0) | 607 (63.2) | |
| > 65 yr | 172 (38.2) | 10 (9.0) | 69 (7.2) |
- Citation: Cao XY, Jia ZF, Jin MS, Cao DH, Kong F, Suo J, Jiang J. Serum pepsinogen II is a better diagnostic marker in gastric cancer. World J Gastroenterol 2012; 18(48): 7357-7361
- URL: https://www.wjgnet.com/1007-9327/full/v18/i48/7357.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i48.7357